
Treatment with second generation zzso zzso can increase the risk of patients with schizophrenia developing zzso zzso and zzso zzso monitoring is recommended, but clinical practice suggests monitoring is not conducted at a rate necessary for these zzso The aim was to audit what proportion of patients were having their weight, zzso zzso body mass index, lipids and blood sugar levels monitored and zzso 

An audit of patients with zzso discharged from three psychiatric zzso was zzso Two data sheets were recorded for every patient and zzso reliability was zzso Data were then entered into zzso and statistical significance zzso 

The sample consisted of 93 zzso zzso were taken by zzso of admitted and zzso of discharged zzso Of these, zzso had their weight recorded, zzso zzso zzso random blood sugar levels, zzso zzso blood sugar levels, zzso zzso zzso and zzso cholesterol and zzso zzso and zzso were not zzso zzso were detected in zzso of recorded zzso and zzso of recorded zzso 

Patients with schizophrenia on zzso have an alarmingly low rate of monitoring of these common adverse effects and zzso zzso need to be aware of this, so that they can improve their zzso 

